JPH07277953A - Production of fat emulsion - Google Patents

Production of fat emulsion

Info

Publication number
JPH07277953A
JPH07277953A JP8756994A JP8756994A JPH07277953A JP H07277953 A JPH07277953 A JP H07277953A JP 8756994 A JP8756994 A JP 8756994A JP 8756994 A JP8756994 A JP 8756994A JP H07277953 A JPH07277953 A JP H07277953A
Authority
JP
Japan
Prior art keywords
emulsion
fat
emulsifier
coarse
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8756994A
Other languages
Japanese (ja)
Other versions
JP3472337B2 (en
Inventor
Kanji Arii
幹治 有井
Shunzo Yamashita
俊三 山下
Yukifumi Kuniba
幸史 国場
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MORISHITA ROUSSEL KK
Morishita Pharmaceuticals Co Ltd
Original Assignee
MORISHITA ROUSSEL KK
Morishita Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MORISHITA ROUSSEL KK, Morishita Pharmaceuticals Co Ltd filed Critical MORISHITA ROUSSEL KK
Priority to JP08756994A priority Critical patent/JP3472337B2/en
Publication of JPH07277953A publication Critical patent/JPH07277953A/en
Application granted granted Critical
Publication of JP3472337B2 publication Critical patent/JP3472337B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To produce a fat emulsion for replenishment of nutrient, capable of being blended with an infusion containing sugar, an electrolyte, an amino acid, etc., without causing change of visual appearance or increase of the size of the fat particle and excellent in shelf life. CONSTITUTION:This method for production of a fat emulsion is carried out by adding water to an emulsifier dispersion containing at least an emulsifier and fats and oils, preparing a coarse emulsion and further refining the coarse emulsion under a high pressure so as to obtain an oil in water type fat emulsion for replenishment of nutrient containing 1 to 30W/V% fats and oils. In this production method, the refining is carried out while controlling the liquid temperature of the emulsion to 5 to 35 deg.C. As the preferable production conditions, preparation of the coarse emulsion at temperatures of the coarse emulsion controlled to 5 to 35 deg.C is used as an additional condition to the above-mentioned production method. Further preferably, dispersion of the emulsifier at liquid temperatures of the emulsifier dispersion controlled to 65 to 95 deg.C is used as an additional condition to the above-mentioned production method.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、脂肪乳剤の製造法に関
し、より詳しくは、糖、電解質、アミノ酸等の栄養輸液
剤と混合しても外観変化や脂肪粒子の粗大化を起こさな
い、保存安定性に優れた栄養補給用脂肪乳剤を製造する
方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a fat emulsion, and more specifically, it does not cause a change in appearance or coarsening of fat particles even when mixed with a nutrient transfusion agent such as sugar, electrolyte, amino acid, etc. The present invention relates to a method for producing a nutritional supplement fat emulsion having excellent stability.

【0002】[0002]

【従来の技術】各種疾患時あるいは術前術後の栄養補給
のために、経静脈栄養法が広く用いられている。この
際、摂取カロリーが不足すると、アミノ酸輸液を投与し
てもアミノ酸がカロリー源として利用されてしまい、十
分な創傷治癒効果が得られないことが知られている。従
って、経静脈栄養法においては、グルコースや脂肪によ
るカロリー補給が重要であり、そのなかでも、脂肪は単
位重量当りの熱量がグルコースの約2倍であるうえ、生
体内に貯蔵される最も大きなカロリー源として優れた利
点を持っている。また、脂肪の投与は、組織細胞の構
成、並びにその正常な機能の遂行に大きく寄与している
リノール酸、リノレイン酸、アラキドン酸などの必須脂
肪酸補給のため栄養学上極めて重要である。ところが、
脂肪を経静脈投与できるように乳化した水中油型の脂肪
乳剤は他の薬剤とは配合禁忌で、例えばアミノ酸、糖、
電解質等の栄養輸液と混合すれば、経時的に外観変化や
脂肪粒子が粗大化する(島田慈彦ら,新薬と臨床,32,71,
1983 )。また、粗大化した脂肪粒子は、強い毒性を示
すことが知られている(横山和正ら,The Japanese Jour
nal of Parenteral and Eenteral Nutrition(サ゛ シ゛ャハ゜ニ
ース゛ シ゛ャーナル オフ゛ ハ゜レンテラル アント゛ニューウトリション),2,615,198
0)。このような背景から、脂肪乳剤は他の栄養輸液と
は配合せず、Y字管を用いて別に投与するか、あるいは
使用直前に混合した後投与していた。
2. Description of the Related Art Parenteral nutrition is widely used for nutritional support during various diseases or before and after surgery. At this time, if the calorie intake is insufficient, it is known that the amino acid is utilized as a calorie source even if the amino acid infusion is administered, and a sufficient wound healing effect cannot be obtained. Therefore, in parenteral nutrition, supplementation of calories with glucose and fat is important. Among them, fat has about twice the calorific value per unit weight of glucose and the largest calorie stored in the body. It has excellent advantages as a source. Further, the administration of fat is extremely important nutritionally because it supplements essential fatty acids such as linoleic acid, linoleic acid, and arachidonic acid, which contribute significantly to the organization of tissue cells and the execution of their normal functions. However,
Oil-in-water fat emulsion emulsified so that fat can be administered intravenously is contraindicated with other drugs, such as amino acids, sugars,
When mixed with nutrient infusions such as electrolytes, appearance changes and fat particles become coarse with time (Shima Shima et al., Shinyaku to Kakuhin, 32, 71,
1983). It is known that coarse fat particles are highly toxic (Kazumasa Yokoyama et al., The Japanese Jour.
nal of Parenteral and Eenteral Nutrition (2,615,198)
0). From such a background, the fat emulsion was not mixed with other nutritional infusion solutions, but was separately administered using a Y-tube, or was mixed and administered immediately before use.

【0003】脂肪乳剤と他の栄養輸液を混合して保存す
る方法としては、例えば、二価金属イオンを含む溶液と
の混合に際して、クエン酸を添加する安定化法が開示さ
れている (特開平5-32541公報)。しかし、この方法
は、クエン酸を静脈内投与した場合、アルカローシスを
引き起こす可能性があること、さらに、血中濃度が 100
mg/dl(約15mEq/l)に達すると、心機能抑制、血圧下降
及び末梢循環不全をもたらすことが知られおり(外科,M
ook,13,116,1980)、安全性の面で好ましい方法とは言
えない。
As a method for mixing and storing a fat emulsion and another nutritional infusion solution, for example, a stabilization method has been disclosed in which citric acid is added when mixing with a solution containing a divalent metal ion. 5-32541 publication). However, this method can cause alkalosis when citrate is administered intravenously, and in addition, blood levels of 100
Reaching mg / dl (about 15mEq / l) is known to lead to cardiac depression, hypotension and peripheral circulatory failure (Surgery, M
ook, 13,116,1980), which is not a preferable method in terms of safety.

【0004】一方、これまでの脂肪乳剤に関する製剤研
究は、いかに平均粒子径が小さく、しかも粗大粒子を含
まない均一で安定な乳化液(エマルジョン)を製造する
かを検討したものが多く、他の栄養輸液剤と混合した際
の保存安定性まで勘案して製造方法を検討したものはな
い。従来の脂肪乳剤の製造法としては、例えば特開平5-
9111公報に記載されているように、水に油脂及び乳化剤
を加えた後、攪拌して粗乳化液を調製し、次いでマント
ンゴーリンホモジナイザーやマイクロフルイダイザーを
用いた高圧乳化法等により精乳化する方法が広く用いら
れている。
On the other hand, many of the past formulation researches on fat emulsions have examined how to produce a uniform and stable emulsion (emulsion) having a small average particle size and not containing coarse particles. There has been no study of the production method in consideration of the storage stability when mixed with the nutritional infusion. As a conventional method for producing a fat emulsion, for example, JP-A-5-
As described in 9111 publication, after adding an oil and fat and an emulsifier to water, a coarse emulsion is prepared by stirring, and then a method of finely emulsifying by a high pressure emulsification method using a Manton-Gaulin homogenizer or a microfluidizer. Is widely used.

【0005】ところが、油脂中に乳化剤を分散させる乳
化剤分散工程、乳化剤分散液に水を加えて粗乳化液を調
製する粗乳化工程さらに粗乳化液を高圧乳化法等により
精乳化する精乳化工程の各製造工程における製造条件と
脂肪乳剤の保存安定性を関連づけて研究した例はない。
従来の検討例を挙げると、例えば、特開平5-9111公報で
は、粗乳化工程の液温が70℃で、精乳化工程の液温が
70℃以下と記載されているに過ぎないし、その温度条
件と保存安定性との関係についての記載はない。また、
80℃に保持された粗乳化液を、直ちに精乳化すると報
告されているが、脂肪乳剤を他の輸液と混合した場合の
保存安定性についての記載はない(石井ら,J.Pharm.Pha
rmacol.(シ゛ャーナル オフ゛ ファーマシー & ファーマコロシ゛ー),42,513,199
0)。
However, an emulsifier dispersion step of dispersing an emulsifier in fats and oils, a coarse emulsification step of preparing water by adding water to the emulsifier dispersion, and a fine emulsification step of finely emulsifying the crude emulsion by a high pressure emulsification method or the like. There have been no studies in which the manufacturing conditions in each manufacturing process and the storage stability of the fat emulsion were related to each other.
As a conventional study example, for example, in JP-A-5-9111, the liquid temperature in the coarse emulsification step is 70 ° C. and the liquid temperature in the fine emulsification step is described as 70 ° C. or less. There is no description about the relationship between the conditions and the storage stability. Also,
Although it has been reported that a crude emulsion maintained at 80 ° C is immediately emulsified, there is no description of storage stability when a fat emulsion is mixed with other infusion solution (Ishii et al., J. Pharm. Pha.
rmacol. (journal off pharmacology & pharmacology), 42,513,199
0).

【0006】このように、従来の製造法では、粗乳化工
程及び精乳化工程からなる脂肪乳剤の乳化工程におい
て、各調製液の液温を50〜80℃と比較的高い温度に
制御している。しかし、前記の製造条件では、脂肪粒子
の平均粒子径が小さく、粗大粒子を含まず均一なエマル
ジョンを製造できるものの、他の栄養輸液剤と混合する
と外観変化や脂肪粒子の粗大化を起こす問題が生ずる。
As described above, in the conventional production method, the liquid temperature of each preparation liquid is controlled to a relatively high temperature of 50 to 80 ° C. in the emulsification process of the fat emulsion comprising the rough emulsification process and the fine emulsification process. . However, under the above-mentioned production conditions, the average particle size of fat particles is small, and although it is possible to produce a uniform emulsion containing no coarse particles, there is a problem that when mixed with other nutrient transfusions, the appearance changes and coarsening of fat particles occurs. Occurs.

【0007】[0007]

【発明が解決しようとする課題】本発明の課題は、糖、
電解質、アミノ酸等の栄養輸液剤と混合しても外観変化
や脂肪粒子の粗大化を起こさない、保存安定性に優れた
栄養補給用脂肪乳剤を提供することにある。
DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention
An object of the present invention is to provide a fat emulsion for nutritional supplementation which is excellent in storage stability and does not cause a change in appearance or coarsening of fat particles even when mixed with a nutritional infusion solution such as an electrolyte or an amino acid.

【0008】[0008]

【課題を解決するための手段】本発明者らは、クエン酸
等の添加剤を使用することなく、脂肪乳剤の各製造工程
の製造条件を適切に制御することで、前述の課題を解決
できないか鋭意検討した。本発明者らは、脂肪乳剤の各
製造工程における各調製液の調製温度が、他の輸液剤と
混合した後の保存安定性を左右する重要な要因であると
の知見を得、その適正な調製温度範囲について検討を重
ねた。
Means for Solving the Problems The present inventors cannot solve the above-mentioned problems by appropriately controlling the manufacturing conditions of each manufacturing process of a fat emulsion without using an additive such as citric acid. I thought about it. The inventors of the present invention have found that the preparation temperature of each preparation liquid in each manufacturing process of a fat emulsion is an important factor that affects the storage stability after mixing with other infusion agents, and the appropriate temperature is obtained. The study on the preparation temperature range was repeated.

【0009】その結果、乳化工程、すなわち粗乳化工程
及び精乳化工程の調製液の温度を至適範囲内に制御する
ことで、他の栄養輸液と混合しても保存安定性の優れた
脂肪乳剤を製造できることを見いだし本発明を完成させ
た。また、各製造工程のなかで、精乳化工程の調製温度
を制御することが最も重要で、その他の製造工程の調製
温度も至適範囲に制御することで、さらに優れた保存安
定性が得られることを見いだした。
As a result, by controlling the temperature of the preparation liquid in the emulsifying step, that is, the rough emulsifying step and the fine emulsifying step within the optimum range, a fat emulsion excellent in storage stability even when mixed with other nutritional infusion solutions. The present invention was completed by finding out that the above can be manufactured. Further, it is most important to control the preparation temperature of the fine emulsification step among the respective production steps, and by controlling the preparation temperature of the other production steps to the optimum range, further excellent storage stability can be obtained. I found a thing.

【0010】すなわち、本発明は、少なくとも乳化剤と
油脂を含有する乳化剤分散液に、水を加えて粗乳化して
粗乳化液を得、この粗乳化液をさらに高圧下で精乳化し
て油脂を1〜30 W/V%含む水中油型の栄養補給用脂肪
乳剤を得る脂肪乳剤の製造法において、前記精乳化にお
ける乳化液の液温を5〜35℃に制御しながら精乳化す
る脂肪乳剤の製造法であり、好ましい製造条件として
は、前述の製造方法に、粗乳化液の液温を5〜35℃に
制御しながら粗乳化する条件を加えた製造方法、より好
ましくは、乳化剤分散液の液温を65〜95℃に制御し
ながら乳化剤を分散させる条件を加えた脂肪乳剤の製造
法である。
That is, according to the present invention, water is added to an emulsifier dispersion liquid containing at least an emulsifier and oil to coarsely emulsify to obtain a coarse emulsified liquid. A method for producing a fat emulsion for obtaining an oil-in-water type fat emulsion for nutritional supplement containing 1 to 30 W / V%, wherein a fat emulsion to be finely emulsified while controlling the liquid temperature of the emulsified liquid in the fine emulsification It is a production method, and preferable production conditions include a production method in which the above-mentioned production method is added to the conditions for coarse emulsification while controlling the liquid temperature of the coarse emulsion to 5 to 35 ° C., more preferably the emulsifier dispersion liquid. This is a method for producing a fat emulsion in which conditions for dispersing an emulsifier are added while controlling the liquid temperature at 65 to 95 ° C.

【0011】本発明は上記の構成からなり、本発明を製
造工程順に詳述すると、第一工程である乳化剤分散工程
における乳化剤分散液の調製は、例えば、高速ホモジナ
イザー、高速ミキサー等を用いて乳化剤を油脂中に分散
させ、乳化剤の固形分が完全に膨潤するまで攪拌するこ
とにより行う。この際、必要に応じて各種の等張化剤を
添加することもできる。また、乳化剤の添加量として
は、油脂重量に対して5〜25%が好ましい。乳化剤分
散工程における乳化剤分散液の調製温度は、65〜95
℃、好ましくは70〜80℃に制御するのがよい。な
お、乳化剤分散液中の乳化剤として使用されるリン脂質
は、油脂に対して5w/v%未満では乳化が不充分となり、
25w/v%を越えると粘度が上昇し、安定な脂肪乳剤が製
造できない。
The present invention has the above-mentioned constitution, and when the present invention is described in detail in the order of manufacturing steps, the preparation of the emulsifier dispersion liquid in the emulsifier dispersion step which is the first step is carried out by using, for example, a high-speed homogenizer, a high-speed mixer or the like. Is dispersed in oil and fat and stirred until the solid content of the emulsifier is completely swollen. At this time, various isotonic agents can be added as required. The amount of the emulsifier added is preferably 5 to 25% based on the weight of the fat and oil. The preparation temperature of the emulsifier dispersion liquid in the emulsifier dispersion step is 65 to 95.
It is good to control the temperature to 70 ° C, preferably 70 to 80 ° C. If the phospholipid used as an emulsifier in the emulsifier dispersion is less than 5 w / v% with respect to fats and oils, the emulsification will be insufficient,
If it exceeds 25 w / v%, the viscosity increases and a stable fat emulsion cannot be produced.

【0012】乳化剤分散工程に続く粗乳化工程における
粗乳化液の調製は、例えば、前述の方法で製造した乳化
剤分散液を、直ちに5〜35℃に冷却、好ましくは15
〜25℃に冷却し、同じく5〜35℃に冷却した注射用
蒸留水を少量ずつ加えて分散させ、高速ホモジナイザ
ー、高速ミキサー等を用いて液温が5〜35℃になるよ
う制御しながら粗乳化液を調製する。
The preparation of the coarse emulsion in the coarse emulsification step following the emulsifier dispersion step is carried out by, for example, immediately cooling the emulsifier dispersion produced by the above-mentioned method to 5 to 35 ° C., preferably 15
Distilled water for injection, which was cooled to -25 ° C and also cooled to 5-35 ° C, was added little by little to disperse, and the mixture was coarsely controlled using a high-speed homogenizer, a high-speed mixer, etc. so that the liquid temperature becomes 5-35 ° C. Prepare an emulsion.

【0013】精乳化工程における精乳化液の調製は、前
記粗乳化液をマントンゴーリンホモジナイザーやマイク
ロフルイダイザーで、液温を5〜35℃に制御しながら
高圧乳化することにより行う。なお、液温制御以外の精
乳化条件としては、5000〜25000PSI、パス
回数5〜25の条件が好ましい条件として挙げられる。
The preparation of the refined emulsion in the refinement step is carried out by high-pressure emulsification of the crude emulsion using a Manton-Gaulin homogenizer or a microfluidizer while controlling the temperature of the solution at 5-35 ° C. In addition, as the conditions for fine emulsification other than the liquid temperature control, conditions of 5000 to 25000 PSI and 5 to 25 passes are preferable.

【0014】前述の各製造工程を経て得られる脂肪乳剤
の平均粒子径は、0.18〜0.36μmである。な
お、平均粒子径がこの範囲からはずれると、他の輸液剤
との混合に際して、安定な脂肪乳剤が製造できない。
The average particle size of the fat emulsion obtained through the above-mentioned manufacturing steps is 0.18 to 0.36 μm. If the average particle diameter is out of this range, a stable fat emulsion cannot be produced when mixed with other infusion agents.

【0015】本発明において使用される油脂は、食用油
であればいずれの油脂も使用でき、例えば大豆油、ヤシ
油、ゴマ油、エゴマ油、アマニ油、綿実油、サフラワー
油等の植物油、鯨油、魚油等の動物油、中鎖脂肪酸トリ
グリセリド等の化学合成トリグリセリドから選ばれた1
種叉は2種以上の油脂が好適に使用できる。また、本発
明に使用される乳化剤は、精製大豆リン脂質、水添大豆
リン脂質、精製卵黄リン脂質、水添卵黄リン脂質、非イ
オン性界面活性剤等の1種または2種以上の組み合わせ
で用いられる。乳化剤としては、好ましくは精製卵黄リ
ン脂質を、より好ましくは精製卵黄リン脂質と非イオン
性の界面活性剤を組み合わせて用いるのがよい。
As the oil and fat used in the present invention, any oil and fat can be used as long as it is an edible oil. For example, vegetable oil such as soybean oil, coconut oil, sesame oil, perilla oil, linseed oil, cottonseed oil and safflower oil, whale oil, 1 selected from animal oil such as fish oil and chemically synthesized triglyceride such as medium chain fatty acid triglyceride
Two or more types of fats and oils can be preferably used. The emulsifier used in the present invention is one or a combination of two or more of purified soybean phospholipids, hydrogenated soybean phospholipids, purified egg yolk phospholipids, hydrogenated egg yolk phospholipids, nonionic surfactants and the like. Used. As the emulsifier, it is preferable to use a purified egg yolk phospholipid, and more preferably to use a purified egg yolk phospholipid in combination with a nonionic surfactant.

【0016】本発明の製造法で得られた脂肪乳剤は、必
要に応じて他の栄養輸液剤、すなわち糖、電解質、アミ
ノ酸と混合して静脈内投与することができる。さらに、
本発明の製造法で得られた脂肪乳剤には、亜鉛、鉄、
銅、ヨウ素、マンガン等の微量元素、ビタミン類等必要
量を考慮して配合することができる。
The fat emulsion obtained by the production method of the present invention may be mixed with other nutritional infusions, that is, sugar, electrolytes and amino acids, if necessary, and administered intravenously. further,
The fat emulsion obtained by the production method of the present invention includes zinc, iron,
It can be blended in consideration of necessary amounts of trace elements such as copper, iodine and manganese, vitamins and the like.

【0017】本発明の製造法において、通常用いられて
いる製剤学的添加剤、すなわち、安定化剤やpH調節剤
などを使用できる。
In the production method of the present invention, the conventionally used pharmaceutical additives, that is, stabilizers and pH adjusters can be used.

【0018】本発明の製造法で得られた脂肪乳剤は、ガ
ラスバイアルや、ポリプロピレン、ポリエチレン、エチ
レン酢酸ビニル共重合体等からなるプラスチックバッグ
等に充填し、空間部を窒素ガスで置換後、常法により滅
菌できる。
The fat emulsion obtained by the production method of the present invention is filled in a glass vial, a plastic bag made of polypropylene, polyethylene, ethylene vinyl acetate copolymer or the like, and the space is replaced with nitrogen gas. It can be sterilized by the method.

【0019】さらに、本発明の製造法で得られた脂肪乳
剤は、例えば脂肪乳剤とグルコースを二室バッグの下層
に充填して高圧蒸気滅菌してもよく、アミノ酸及び電解
質を残りの上層に充填し、冷後又は使用前に二室間を連
通することによって、他の輸液剤と混合してもよい。二
室バッグは、例えばプラスチック製の柔軟な袋状容器で
あって、その中央部が帯状に剥離可能に熱溶着され、厳
密に隔離された二室のそれぞれに輸液注入口叉は排出口
が設けられたものが使用できる。
Furthermore, the fat emulsion obtained by the production method of the present invention may be sterilized by high pressure steam by filling the lower layer of the two-chamber bag with the fat emulsion and glucose, and filling the remaining upper layer with the amino acid and the electrolyte. However, it may be mixed with another infusion agent by communicating between the two chambers after cooling or before use. The two-chamber bag is, for example, a flexible bag-shaped container made of plastic, the central portion of which is heat-weld in a strip-like manner so that it can be peeled off, and an infusion inlet or an outlet is provided in each of the two chambers that are strictly isolated. You can use the specified one.

【0020】以下、実施例に基づいて本発明をより詳細
に説明するが、本発明はこれらの実施例に限定されるも
のではない。
The present invention will be described in more detail based on the following examples, but the invention is not intended to be limited to these examples.

【0021】[0021]

【実施例1】精製大豆油30.0g、グリセリン7.5
g及び精製卵黄リン脂質3.6gを80℃に制御しなが
ら、ポリトロン高速ホモジナイザーを用い、完全に膨潤
するまで激しく攪拌し、乳化剤分散液を調製した。この
乳化剤分散液を、直ちに20℃に冷却し、注射用蒸留水
30mlを少量ずつ加え、20℃に制御しながら、ポリ
トロン高速ホモジナイザーで粗乳化液を調製した。こう
して得られた粗乳化液を、直ちにマイクロフルイダイザ
ー(M−110Y型)を用い、20℃に液温を制御しな
がら、10000PSIにて精乳化した。次に、精乳化
液に注射用蒸留水を加えて全量を300mlとし、3.
0μmのメンブランフィルターでろ過した後、100m
lガラスバイアルに充填、窒素置換後密栓し、常法に従
って高圧蒸気滅菌を行い、目的とする脂肪乳剤を調製し
た。
Example 1 30.0 g of refined soybean oil and 7.5 glycerin
g and purified egg yolk phospholipids (3.6 g) were vigorously stirred using a Polytron high-speed homogenizer while controlling the temperature to 80 ° C. to prepare an emulsifier dispersion liquid. This emulsifier dispersion liquid was immediately cooled to 20 ° C., 30 ml of distilled water for injection was added little by little, and a polyemulsion high-speed homogenizer was used to prepare a crude emulsion liquid while controlling at 20 ° C. The thus-obtained crude emulsion was immediately emulsified at 10,000 PSI using a microfluidizer (M-110Y type) while controlling the liquid temperature at 20 ° C. Next, distilled water for injection was added to the refined emulsion to make the total amount 300 ml.
100m after filtering with 0μm membrane filter
l A glass vial was filled, purged with nitrogen and sealed, and high-pressure steam sterilization was performed according to a conventional method to prepare a target fat emulsion.

【0022】[0022]

【実施例2】粗乳化液の調製温度と精乳化液の調製温度
を35℃に設定した他は、実施例1と同様にして脂肪乳
剤を調製した。
Example 2 A fat emulsion was prepared in the same manner as in Example 1 except that the preparation temperature of the crude emulsion and the preparation temperature of the refined emulsion were set to 35 ° C.

【0023】[0023]

【実施例3】精製大豆油31.0g及び精製卵黄レシチ
ン3.72gを80℃に制御しながら、ポリトロン高速
ホモジナイザーを用い激しく攪拌し、乳化剤分散液を調
製した。この乳化剤分散液を、直ちに20℃に冷却し、
50%グルコース液31mlを少量ずつ加え、20℃に
制御しながら、ポリトロン高速ホモジナイザーで粗乳化
液を調製した。こうして得られた粗乳化液を、直ちにマ
イクロフルイダイザー(M−110Y型)を用い、20
℃に制御しながら、10000PSIにて精乳化を行っ
た。次に、精乳化液に、予めグルコース59.5g及び
リン酸二水素ナトリウム(二水和物)0.78gを溶解
した水溶液300mlを加え、さらに蒸留水で全液量を
700mlに調整した。この溶液を孔径3.0μmのメ
ンブランフィルターで濾過し、二室バッグの下層に充填
し、空間部を窒素ガスで置換後密栓した。次に、下記表
1に示した上層組成物を、注射用蒸留水に加温溶解して
250mlとし、1規定の酢酸水溶液でpHを7.0に
調整した後、全量を300mlとした。この溶液を孔径
0.22μmのメンブランフィルターで濾過し、二室バ
ッグの上層に充填し、空間部を窒素ガスで置換後密栓
し、常法にしたがって高圧蒸気滅菌を行った。
Example 3 31.0 g of purified soybean oil and 3.72 g of purified egg yolk lecithin were vigorously stirred using a Polytron high speed homogenizer while controlling at 80 ° C. to prepare an emulsifier dispersion liquid. Immediately cool this emulsifier dispersion to 20 ° C.,
31 ml of 50% glucose solution was added little by little, and a crude emulsion was prepared with a Polytron high speed homogenizer while controlling at 20 ° C. The crude emulsion thus obtained was immediately used for 20 minutes using a microfluidizer (M-110Y type).
While controlling the temperature to be 0 ° C., fine emulsification was performed at 10,000 PSI. Next, 300 ml of an aqueous solution in which 59.5 g of glucose and 0.78 g of sodium dihydrogen phosphate (dihydrate) were dissolved in advance was added to the refined emulsion, and the total amount of the solution was adjusted to 700 ml with distilled water. This solution was filtered through a membrane filter having a pore size of 3.0 μm, filled in the lower layer of the two-chamber bag, and the space was replaced with nitrogen gas and then sealed. Next, the upper layer composition shown in Table 1 below was dissolved in distilled water for injection under heating to 250 ml, and the pH was adjusted to 7.0 with 1N aqueous acetic acid solution, and then the total amount was 300 ml. This solution was filtered through a membrane filter having a pore size of 0.22 μm, filled in the upper layer of the two-chamber bag, the space was replaced with nitrogen gas, and the container was sealed, and subjected to high-pressure steam sterilization according to a conventional method.

【0024】[0024]

【表1】 [Table 1]

【0025】[0025]

【試験例1】各実施例及び以下に述べる対照例の脂肪乳
剤を被験液として、各被験液の製造直後の品質と、その
他の栄養輸液と混合した後の保存安定性を調べた。各被
験液と混合する試験液として、表2に示される組成から
なる糖、電解質及びアミノ酸液を注射用蒸留水に溶解し
て900mlとし、酢酸水溶液でpHを6.2に調整
後、全量を1000mlとしたものを用いた。各被検液
と前記試験液との混合は、試験液を孔径0.22μmの
メンブランフィルターでろ過した後、各被検液62ml
に、それぞれ試験液を138mlづつ無菌的に200m
lプラスチックバッグに混注して行った。保存安定性
は、前記混合操作後、2日間保存(25℃)した混合液
の外観変化及び脂肪粒子中の粗大粒子の割合を調べるこ
とにより評価した。なお、遠心沈降法により測定した2
μm以上脂肪粒子の割合を、粗大粒子の割合とした。表
3に、各被検液の製造直後(高圧乳化処理後)の粗大粒
子の割合と脂肪粒子の平均粒径、さらに保存安定性の評
価結果を示した。試験の結果より、各製造工程の調製温
度を至適範囲に制御した実施例1と実施例2は共に、製
造直後に粗大粒子が生成することなく、且つ保存安定性
も問題のないことが明らかとなった。しかし、表3に示
すような、実施例1及び実施例2とは異なった調製温度
で製造した対照例1〜5の脂肪乳剤は、いずれも製造直
後の品質が好ましくないか、あるいは保存安定性に問題
があるとの評価結果が得られた。さらに、実施例1と乳
化剤分散工程の調製温度を100℃とした以外は実施例
1同様にして調製した対照例6の製造直後の遊離脂肪酸
を測定した結果、実施例1では、遊離脂肪酸が0.31
mEq/lであるのに対し、対照例6では1.24mE
q/lと明かな高値を示し油脂が分解していた。以上の
結果から、脂肪乳剤の製造において、粗乳化工程及び精
乳化工程における調製温度と乳化剤分散時の調製温度に
至適範囲が存在することが明らかとなった。
[Test Example 1] Using the fat emulsions of Examples and Control Examples described below as test liquids, the quality of each test liquid immediately after production and the storage stability after mixing with other nutritional infusion solutions were examined. As a test solution to be mixed with each test solution, a sugar, an electrolyte and an amino acid solution having the composition shown in Table 2 were dissolved in distilled water for injection to 900 ml, and the pH was adjusted to 6.2 with an acetic acid aqueous solution, and then the total amount was changed. What was made 1000 ml was used. 62 ml of each test liquid was prepared by mixing the test liquid with the test liquid after filtering the test liquid with a membrane filter having a pore diameter of 0.22 μm.
And aseptically 200m each of 138ml of test solution.
It was performed by co-injecting into a plastic bag. The storage stability was evaluated by examining the appearance change of the mixed solution stored for 2 days (25 ° C.) after the above mixing operation and examining the ratio of coarse particles in the fat particles. In addition, 2 measured by the centrifugal sedimentation method
The ratio of fat particles of μm or more was defined as the ratio of coarse particles. Table 3 shows the proportion of coarse particles immediately after the production of each test liquid (after high-pressure emulsification treatment), the average particle diameter of fat particles, and the evaluation results of storage stability. From the test results, it is clear that in both Example 1 and Example 2 in which the preparation temperature of each production process was controlled within the optimum range, coarse particles were not generated immediately after production and there was no problem in storage stability. Became. However, as shown in Table 3, the fat emulsions of Comparative Examples 1 to 5 produced at different preparation temperatures from those of Examples 1 and 2 are not preferable in quality immediately after production, or have storage stability. The evaluation result that there is a problem was obtained. Further, as a result of measuring the free fatty acid immediately after the production of Comparative Example 6 prepared in the same manner as in Example 1 except that the preparation temperature in Example 1 and the emulsifier dispersion step was 100 ° C., the free fatty acid in Example 1 was 0. .31
mEq / l, while Comparative Example 6 has 1.24 mE
It showed a clear high value of q / l and the oil and fat had decomposed. From the above results, it has been clarified that in the production of the fat emulsion, the preparation temperature in the rough emulsification step and the fine emulsification step and the preparation temperature at the time of dispersing the emulsifier have optimum ranges.

【0026】[0026]

【表2】 [Table 2]

【0027】[0027]

【表3】 [Table 3]

【0028】[0028]

【試験例2】実施例3の二室バッグ輸液製剤の二室間を
連通し、25℃で2日間保存した後の外観変化を観察
し、さらに、遠心沈降法により2μm以上の粗大粒子の
割合を測定したところ、外観の変化は認められず、且つ
2μm以上の粗大粒子の生成も全く認められなかった。
[Test Example 2] The two-chamber infusion preparation of Example 3 was communicated between the two chambers and observed for change in appearance after storage at 25 ° C. for 2 days. Further, the proportion of coarse particles of 2 μm or more was measured by a centrifugal sedimentation method. No change in appearance was observed, and no formation of coarse particles of 2 μm or more was observed.

【0029】[0029]

【発明の効果】本発明によれば、他の栄養輸液、すなわ
ちグルコース、電解質及びアミノ酸輸液と混合しても、
外観変化や脂肪粒子の粗大化を起こさない、保存安定性
の優れた脂肪乳剤を製造することができる。
According to the present invention, when mixed with other nutritional infusions, namely glucose, electrolytes and amino acid infusions,
It is possible to produce a fat emulsion having excellent storage stability that does not cause a change in appearance or coarsening of fat particles.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 少なくとも乳化剤と油脂を含有する乳化
剤分散液に、水を加えて粗乳化して粗乳化液を得、この
粗乳化液をさらに高圧下で精乳化して油脂を1〜30 W
/V%含む水中油型の栄養補給用脂肪乳剤を得る脂肪乳剤
の製造法において、前記精乳化における乳化液の液温を
5〜35℃に制御しながら精乳化するすることを特徴と
する脂肪乳剤の製造法。
1. An emulsifier dispersion containing at least an emulsifier and fats and oils is added with water to roughly emulsify to obtain a coarse emulsified liquid, and the coarse emulsified liquid is further finely emulsified under high pressure to obtain fats and oils of 1 to 30 W.
In the method for producing a fat emulsion for obtaining an oil-in-water type fat emulsion for nutritional supplementation, the fat is characterized in that it is emulsified while controlling the liquid temperature of the emulsified liquid in the above-mentioned emulsification to 5 to 35 ° C. Emulsion manufacturing method.
【請求項2】 粗乳化液の液温を5〜35℃に制御しな
がら粗乳化することを特徴とする請求項1記載の脂肪乳
剤の製造法。
2. The method for producing a fat emulsion according to claim 1, wherein the coarse emulsion is carried out while controlling the liquid temperature of the coarse emulsion to 5 to 35 ° C.
【請求項3】 乳化剤分散液の液温を65〜95℃に制
御しながら乳化剤を分散させることを特徴とする請求項
2記載の脂肪乳剤の製造法。
3. The method for producing a fat emulsion according to claim 2, wherein the emulsifier is dispersed while controlling the liquid temperature of the emulsifier dispersion liquid at 65 to 95 ° C.
JP08756994A 1994-03-31 1994-03-31 Production method of fat emulsion Expired - Fee Related JP3472337B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP08756994A JP3472337B2 (en) 1994-03-31 1994-03-31 Production method of fat emulsion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP08756994A JP3472337B2 (en) 1994-03-31 1994-03-31 Production method of fat emulsion

Publications (2)

Publication Number Publication Date
JPH07277953A true JPH07277953A (en) 1995-10-24
JP3472337B2 JP3472337B2 (en) 2003-12-02

Family

ID=13918638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP08756994A Expired - Fee Related JP3472337B2 (en) 1994-03-31 1994-03-31 Production method of fat emulsion

Country Status (1)

Country Link
JP (1) JP3472337B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103610049A (en) * 2013-11-26 2014-03-05 刘克武 Elderberry fruit oil oral emulsion and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103610049A (en) * 2013-11-26 2014-03-05 刘克武 Elderberry fruit oil oral emulsion and preparation method thereof

Also Published As

Publication number Publication date
JP3472337B2 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
US5034414A (en) Liquid emulsion for transfusion
JPH07507327A (en) Nutritional formulations for humans with nervous system damage
JPS60149524A (en) Prostaglandin fat emulsion
JPS5924132B2 (en) Manufacturing method for nutritional supplement emulsion
JPS59216820A (en) Fat emulsion of prostaglandin
EP0700681A1 (en) Nutritional transfusion for peripheral vein administration
TWI749451B (en) Pharmaceutical composition comprising omega fatty acids, and infusion preparation comprising the same
CN105939705A (en) Composition comprising EPA and DHA triglycerides for parenteral administration
JP2930242B2 (en) Emulsion for parenteral administration
JPS58162517A (en) Fat-soluble vitamin-containing fatty emulsion
JPS60192547A (en) Edible liquid compounded oil
JP3132085B2 (en) Fat emulsion
JP3472337B2 (en) Production method of fat emulsion
JPS62123113A (en) Fatty emulsion containing ubidecarenone
JPH09157179A (en) Liquid nourishing composition
JP3695499B2 (en) Fat emulsion
JP3723992B2 (en) Fat-containing infusion preparation and comprehensive nutrition infusion container containing it
Du Plessis et al. The stability of parenteral fat emulsions in nutrition mixtures
JP2950348B2 (en) Fat emulsion and method for producing the same
JPS62221629A (en) Production of phospholipid emulsion
JPS60237017A (en) Fat transfusion solution agent
JP3615284B2 (en) Production method of fat emulsion
JP4148632B2 (en) Peripheral parenteral nutrition infusion
CN112516086B (en) Breynolone fat emulsion for injection and preparation method thereof
JPH0565220A (en) Transfusion pharmaceutical

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees